Global Benign Prostatic Hyperplasia (BPH) Laser Therapy Market Strategic Research Report

Scope of the Report

The global Benign Prostatic Hyperplasia (BPH) Laser Therapy market size is predicted to grow from US$ 8,772 million in 2025 to US$ 13,830 million in 2032; it is expected to grow at a CAGR of 6.8% from 2026 to 2032.

BPH or benign prostatic hyperplasia or hypertrophy is a benign enlargement of the prostate.BPH Laser Therapy is a minimally invasive procedure for BPH (benign prostatic hyperplasia) that uses laser energy to remove enlarged prostate tissue, resulting in an open channel for urine flow-through and a quick return to a life with dramatically improved BPH symptoms.Benign prostate hyperplasia (BPH), while not cancer, can causes symptoms such as bladder stones, blood in the urine and an inability to urinate.

The global market for Benign Prostatic Hyperplasia (BPH) Laser Therapy focuses on providing therapeutic solutions for the treatment of BPH using laser technologies. BPH, also known as prostate gland enlargement, is a common condition among aging men that can cause urinary symptoms and affect quality of life. Laser therapy offers a minimally invasive approach to treat BPH, providing benefits such as reduced bleeding and quicker recovery compared to traditional surgical methods.

Market Overview: The market for BPH laser therapy is driven by the increasing prevalence of BPH and the growing demand for minimally invasive treatment options. The market includes various laser technologies and devices used for the treatment of BPH.

Laser Treatment Options: BPH laser therapy involves the use of laser energy to remove or vaporize excess prostate tissue, thus relieving symptoms and improving urinary flow. Different laser modalities used for BPH treatment include GreenLight laser (laser vaporization), holmium laser enucleation of the prostate (HoLEP), thulium laser, and others.

Advantages Over Traditional Surgical Methods: BPH laser therapy offers several advantages over traditional surgical methods. It is minimally invasive, resulting in shorter hospital stays, reduced risk of complications, and faster recovery times. Laser therapy also allows for precise tissue ablation, minimizing damage to surrounding structures.

Market Factors: The market growth for BPH laser therapy is driven by factors such as the increasing geriatric population, rising awareness about minimally invasive treatment options, technological advancements in laser devices, and the proven efficacy of laser therapy in BPH management.

Key Players: The market includes medical device companies that specialize in developing and marketing laser systems for BPH treatment. These companies may offer a range of laser devices, accessories, and associated services.

This report presents a comprehensive overview of the global Benign Prostatic Hyperplasia (BPH) Laser Therapy market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Holmium Laser
• Thulium Laser
• Green Light Laser
• Others

Segment by Application

• Hospitals
• Clinics
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Benign Prostatic Hyperplasia (BPH) Laser Therapy market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospitals, Clinics, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact